InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,634.61
(
1.15%
)
US TECH 100
19,202.80
(
1.10%
)
Dow Jones
41,175.08
(
1.14%
)
Brent Oil
78.38
(
0.00%
)
Bitcoin
64,367.10
(
0.41%
)
Post# of 252963
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 837
Posts 120329
Boards Moderated 18
Alias Born 09/05/2002

DewDiligence

Member Level

Re: dewophile post# 252562

Thursday, 07/11/2024 12:45:43 PM

Thursday, July 11, 2024 12:45:43 PM

Post# of 252963
Re: PFE’s oral weight-loss pipeline

PFE is playing from behind, and they may not have the best molecule to boot, but they do have another undisclosed MOA in the clinic so if they can pair the two together this could open a window for success.

PFE actually has three oral weight-loss compounds in its pipeline other than Danuglipron: two are GLP-1s that are (presumably) better than Danuglipron; and one has an undisclosed MoA. Mufaso’s compilation in #msg-174727339 lists all three of them.

Nevertheless, I concur with your musings above.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up